US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Galectin Therapeutics

5.74

-0.5600-8.89%

Post-market: 5.740.00000.00%19:33 EST

Volume:774.14K

Turnover:4.66M

Market Cap:370.07M

PE:-9.72

High:6.66

Open:6.28

Low:5.67

Close:6.30

52wk High:6.66

52wk Low:0.7260

Shares:64.47M

Float Shares:44.93M

Volume Ratio:1.95

T/O Rate:1.72%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5905

EPS(LYR):-0.7575

ROE:-3727.94%

ROA:-87.09%

PB:-2.94

PE(LYR):-7.58

Loading ...

Overview Company News Filings

Galectin Therapeutics unveils new data on galectin-3 inhibitor belapectin for MASH cirrhosis and cancer therapy

10X Fund, L.P. Reports Disposal of Galectin Therapeutics Inc. Common Shares

Galectin Therapeutics Inc. Publishes Transcript of NAVIGATE Trial Update Event

Galectin Therapeutics CEO Joel Lewis Reports Disposal of Common Shares

Galectin Therapeutics Chief Medical Officer Jamil Khurram Reports Disposal of Common Shares

Promising Phase 2 Data Boosts Confidence in Galectin Therapeutics’ Belapectin for Fibrotic Disease Treatment

Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update

Galectin Therapeutics: Submitted Navigate Data Package to FDA and Requested Feedback on Proposed Next Steps, Guidance Anticipated by Year-End

THOMSON REUTERS

Galectin Therapeutics Inc: Qtrly Loss per Share $0.13

THOMSON REUTERS

Galectin Therapeutics reports Q3 2025 financial results and updates on belapectin trial data

10X Fund, L.P. Reports Disposal of Galectin Therapeutics Inc. Common Shares

Galectin Therapeutics CFO Jack W. Callicutt Reports Disposal of Common Shares

Galectin Therapeutics unveils pipeline progress on galectin-3 inhibitor for MASH cirrhosis and cancer

Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting

Galectin Therapeutics Reports Positive Phase 2 NAVIGATE Trial Results for Belapectin in MASH Cirrhosis

Galectin Therapeutics CFO Jack W. Callicutt Reports Disposal of Common Shares

Galectin Therapeutics CEO Joel Lewis Reports Disposal of Common Shares

10X Fund, L.P. Reports Disposal of Galectin Therapeutics Inc. Common Shares

Galectin Therapeutics Inc. Announces Date for 2025 Annual Stockholders Meeting

Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GALT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GALT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GALT\",,,,,undefined,":{"symbol":"GALT","market":"US","secType":"STK","nameCN":"Galectin Therapeutics","latestPrice":5.74,"timestamp":1764968400000,"preClose":6.3,"halted":0,"volume":774143,"hourTrading":{"tag":"盘后","latestPrice":5.74,"preClose":5.74,"latestTime":"19:33 EST","volume":52,"amount":316.054,"timestamp":1764981217132},"delay":0,"floatShares":44925282,"shares":64472792,"eps":-0.59053,"marketStatus":"Market Closed","change":-0.56,"latestTime":"12-05 16:00:00 EST","open":6.28,"high":6.66,"low":5.67,"amount":4656271.190249,"amplitude":0.157143,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.59053,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1063166400000,"exchange":"NASDAQ","adjPreClose":6.3,"preHourTrading":{"tag":"盘前","latestPrice":6.49,"preClose":6.3,"latestTime":"08:04 EST","volume":185,"amount":1196.412464,"timestamp":1764939895627},"postHourTrading":{"tag":"盘后","latestPrice":5.74,"preClose":5.74,"latestTime":"19:33 EST","volume":52,"amount":316.054,"timestamp":1764981217132},"volumeRatio":1.9501307153315006,"impliedVol":1.4953,"impliedVolPercentile":0.52},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GALT\",,,,,undefined,":{"symbol":"GALT","floatShares":44925282,"roa":"-87.09%","roe":"-3727.94%","lyrEps":-0.757514,"volumeRatio":1.9501307153315006,"shares":64472792,"dividePrice":0,"high":6.66,"amplitude":0.157143,"preClose":6.3,"low":5.67,"week52Low":0.726041,"pbRate":"-2.94","week52High":6.66,"institutionHeld":0.1798,"latestPrice":5.74,"eps":-0.59053,"divideRate":0,"volume":774143,"delay":0,"ttmEps":-0.59053,"open":6.28,"prevYearClose":1.29,"prevWeekClose":5.73,"prevMonthClose":5.73,"prevQuarterClose":4.235,"fiveDayClose":5.73,"twentyDayClose":5.58,"sixtyDayClose":5.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GALT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"GALT","fiscalQuarterEnding":"2025/09","expectedEps":-0.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2025-08-14","symbol":"GALT","fiscalQuarterEnding":"2025/06","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2025-05-15","symbol":"GALT","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2025-03-31","symbol":"GALT","fiscalQuarterEnding":"2024/12","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2024-11-14","symbol":"GALT","fiscalQuarterEnding":"2024/09","expectedEps":-0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GALT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GALT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1750136400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GALT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GALT","date":"2025-12-05","current":-9.720082,"percent":0.000801,"low":-12.422576,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"high":-1.170388,"avg":-4.113474,"sd":2.143334,"marketCap":406178589},"quantilePoints":[{"date":"2020-12-11","current":-7.151824,"twenty":-15.295704,"median":-8.563433,"eighty":-2.859787,"marketCap":148400343},{"date":"2020-12-18","current":-7.124317,"twenty":-15.295704,"median":-8.563433,"eighty":-2.859787,"marketCap":147829572},{"date":"2020-12-24","current":-6.656697,"twenty":-15.295704,"median":-8.563433,"eighty":-2.859787,"marketCap":138126473},{"date":"2020-12-31","current":-6.161571,"twenty":-15.295704,"median":-8.563433,"eighty":-2.859787,"marketCap":127852603},{"date":"2021-01-08","current":-6.134064,"twenty":-15.295704,"median":-8.563433,"eighty":-2.859787,"marketCap":127281832},{"date":"2021-01-15","current":-6.024036,"twenty":-15.295704,"median":-8.563433,"eighty":-2.864657,"marketCap":124998750},{"date":"2021-01-22","current":-5.969022,"twenty":-15.295704,"median":-8.563433,"eighty":-2.878479,"marketCap":123857209},{"date":"2021-01-29","current":-5.391375,"twenty":-15.295704,"median":-8.563433,"eighty":-2.883839,"marketCap":111871027},{"date":"2021-02-05","current":-6.271599,"twenty":-15.295704,"median":-8.563433,"eighty":-2.902952,"marketCap":130135685},{"date":"2021-02-12","current":-6.849247,"twenty":-15.295704,"median":-8.563433,"eighty":-2.924913,"marketCap":142121866},{"date":"2021-02-19","current":-6.464148,"twenty":-15.295704,"median":-8.563433,"eighty":-2.926466,"marketCap":134131079},{"date":"2021-02-26","current":-6.161571,"twenty":-15.295704,"median":-8.563433,"eighty":-2.93862,"marketCap":127852603},{"date":"2021-03-05","current":-6.106557,"twenty":-15.297441,"median":-8.565939,"eighty":-2.973953,"marketCap":126711062},{"date":"2021-03-12","current":-6.35412,"twenty":-15.295704,"median":-8.563433,"eighty":-2.987868,"marketCap":131847997},{"date":"2021-03-19","current":-6.189078,"twenty":-15.295704,"median":-8.563433,"eighty":-3.012497,"marketCap":128423373},{"date":"2021-03-26","current":-5.914008,"twenty":-15.295704,"median":-8.560927,"eighty":-3.065101,"marketCap":122715668},{"date":"2021-04-01","current":-5.358758,"twenty":-15.295704,"median":-8.560927,"eighty":-3.105175,"marketCap":125743266},{"date":"2021-04-09","current":-6.381794,"twenty":-15.295704,"median":-8.563433,"eighty":-3.199013,"marketCap":149748798},{"date":"2021-04-16","current":-5.3344,"twenty":-15.295704,"median":-8.563433,"eighty":-3.262048,"marketCap":125171705},{"date":"2021-04-23","current":-9.523975,"twenty":-15.295704,"median":-8.573999,"eighty":-3.280494,"marketCap":223480077},{"date":"2021-04-30","current":-10.766233,"twenty":-15.295704,"median":-8.593355,"eighty":-3.329326,"marketCap":252629652},{"date":"2021-05-07","current":-9.743197,"twenty":-15.295704,"median":-8.640538,"eighty":-3.388304,"marketCap":228624120},{"date":"2021-05-14","current":-10.303431,"twenty":-15.295704,"median":-8.661856,"eighty":-3.435393,"marketCap":241770006},{"date":"2021-05-21","current":-9.406898,"twenty":-15.295704,"median":-8.820349,"eighty":-3.467861,"marketCap":246902849},{"date":"2021-05-28","current":-8.787149,"twenty":-15.295704,"median":-8.847147,"eighty":-3.524016,"marketCap":230636308},{"date":"2021-06-04","current":-8.521543,"twenty":-15.295704,"median":-8.885204,"eighty":-3.577222,"marketCap":223664933},{"date":"2021-06-11","current":-8.300204,"twenty":-15.295704,"median":-8.885204,"eighty":-3.611891,"marketCap":217855455},{"date":"2021-06-18","current":-6.90577,"twenty":-15.295704,"median":-8.885204,"eighty":-3.668321,"marketCap":181255738},{"date":"2021-06-25","current":-7.636188,"twenty":-15.295704,"median":-8.885204,"eighty":-3.697097,"marketCap":200427018},{"date":"2021-07-02","current":-7.016439,"twenty":-15.295704,"median":-8.885204,"eighty":-3.710255,"marketCap":184160477},{"date":"2021-07-09","current":-7.636188,"twenty":-15.295704,"median":-8.885204,"eighty":-3.734808,"marketCap":200427018},{"date":"2021-07-16","current":-5.887611,"twenty":-15.295704,"median":-8.885204,"eighty":-3.740931,"marketCap":154532136},{"date":"2021-07-23","current":-5.887611,"twenty":-15.295704,"median":-8.885204,"eighty":-3.766326,"marketCap":154532136},{"date":"2021-07-30","current":-6.086816,"twenty":-15.295704,"median":-8.885204,"eighty":-3.800884,"marketCap":159760667},{"date":"2021-08-06","current":-7.614054,"twenty":-15.295704,"median":-8.885204,"eighty":-3.822389,"marketCap":199846070},{"date":"2021-08-13","current":-7.481251,"twenty":-15.295704,"median":-8.885204,"eighty":-3.860878,"marketCap":196360383},{"date":"2021-08-20","current":-6.988904,"twenty":-15.295704,"median":-8.885204,"eighty":-3.876637,"marketCap":199756854},{"date":"2021-08-27","current":-8.046572,"twenty":-15.295704,"median":-8.885204,"eighty":-3.908335,"marketCap":229987120},{"date":"2021-09-03","current":-7.984356,"twenty":-15.295704,"median":-8.885204,"eighty":-3.939585,"marketCap":228208869},{"date":"2021-09-10","current":-7.92214,"twenty":-15.295704,"median":-8.885204,"eighty":-3.957281,"marketCap":226430618},{"date":"2021-09-17","current":-8.419867,"twenty":-15.295704,"median":-8.885204,"eighty":-3.987933,"marketCap":240656625},{"date":"2021-09-24","current":-8.60868,"twenty":-15.295704,"median":-8.885204,"eighty":-4.000882,"marketCap":246053300},{"date":"2021-10-01","current":-7.882647,"twenty":-15.295704,"median":-8.885204,"eighty":-4.025006,"marketCap":225301817},{"date":"2021-10-08","current":-7.218845,"twenty":-15.295704,"median":-8.885204,"eighty":-4.111138,"marketCap":206329032},{"date":"2021-10-15","current":-6.990663,"twenty":-15.295704,"median":-8.885204,"eighty":-4.188898,"marketCap":199807138},{"date":"2021-10-22","current":-6.803969,"twenty":-15.295704,"median":-8.885204,"eighty":-4.244161,"marketCap":194471042},{"date":"2021-10-29","current":-6.575787,"twenty":-15.295704,"median":-8.885204,"eighty":-4.336778,"marketCap":187949147},{"date":"2021-11-05","current":-6.638019,"twenty":-15.295704,"median":-8.885204,"eighty":-4.478855,"marketCap":189727846},{"date":"2021-11-12","current":-6.243886,"twenty":-15.295704,"median":-8.885204,"eighty":-4.686212,"marketCap":178462755},{"date":"2021-11-19","current":-5.123182,"twenty":-15.295704,"median":-8.885204,"eighty":-4.881707,"marketCap":159628110},{"date":"2021-11-26","current":-4.894639,"twenty":-15.295704,"median":-8.885204,"eighty":-4.921463,"marketCap":152507153},{"date":"2021-12-03","current":-4.342325,"twenty":-15.295704,"median":-8.885204,"eighty":-4.963117,"marketCap":135298175},{"date":"2021-12-10","current":-4.266144,"twenty":-15.295704,"median":-8.885204,"eighty":-4.963117,"marketCap":132924523},{"date":"2021-12-17","current":-4.532778,"twenty":-15.295704,"median":-8.885204,"eighty":-4.963117,"marketCap":141232305},{"date":"2021-12-23","current":-4.513733,"twenty":-15.295704,"median":-8.885204,"eighty":-4.963117,"marketCap":140638892},{"date":"2021-12-31","current":-3.942374,"twenty":-15.295704,"median":-8.885204,"eighty":-4.963117,"marketCap":122836501},{"date":"2022-01-07","current":-4.018556,"twenty":-15.295704,"median":-8.885204,"eighty":-4.929242,"marketCap":125210153},{"date":"2022-01-14","current":-3.847148,"twenty":-15.295704,"median":-8.885204,"eighty":-4.906066,"marketCap":119869436},{"date":"2022-01-21","current":-3.656695,"twenty":-15.295704,"median":-8.885204,"eighty":-4.906066,"marketCap":113935305},{"date":"2022-01-28","current":-3.485288,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":108594588},{"date":"2022-02-04","current":-4.075691,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":126990392},{"date":"2022-02-11","current":-3.96142,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":123429914},{"date":"2022-02-18","current":-3.809057,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":118682610},{"date":"2022-02-25","current":-3.618604,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":112748479},{"date":"2022-03-04","current":-3.45672,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":107704468},{"date":"2022-03-11","current":-3.35197,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":104440696},{"date":"2022-03-18","current":-3.523378,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":109781414},{"date":"2022-03-25","current":-3.31388,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":103253870},{"date":"2022-04-01","current":-3.072214,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":93785470},{"date":"2022-04-08","current":-3.111103,"twenty":-15.295704,"median":-8.871581,"eighty":-4.892053,"marketCap":94972628},{"date":"2022-04-14","current":-3.383324,"twenty":-15.295704,"median":-8.871581,"eighty":-4.751506,"marketCap":103282733},{"date":"2022-04-22","current":-3.227769,"twenty":-15.295704,"median":-8.871581,"eighty":-4.677593,"marketCap":98534102},{"date":"2022-04-29","current":-3.013881,"twenty":-15.295704,"median":-8.871581,"eighty":-4.588211,"marketCap":92004734},{"date":"2022-05-06","current":-2.841992,"twenty":-15.295704,"median":-8.871581,"eighty":-4.490196,"marketCap":86757496},{"date":"2022-05-13","current":-2.644437,"twenty":-15.295704,"median":-8.871581,"eighty":-4.397451,"marketCap":80726734},{"date":"2022-05-20","current":-2.227874,"twenty":-15.295704,"median":-8.871581,"eighty":-4.397451,"marketCap":76017303},{"date":"2022-05-27","current":-2.297495,"twenty":-15.295704,"median":-8.871581,"eighty":-4.397451,"marketCap":78392843},{"date":"2022-06-03","current":-2.454143,"twenty":-15.295704,"median":-8.871581,"eighty":-4.397451,"marketCap":83737810},{"date":"2022-06-10","current":-2.401927,"twenty":-15.295704,"median":-8.871581,"eighty":-4.397451,"marketCap":81956154},{"date":"2022-06-17","current":-2.088632,"twenty":-15.295704,"median":-8.871581,"eighty":-4.397451,"marketCap":71266221},{"date":"2022-06-24","current":-2.193064,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":74829532},{"date":"2022-07-01","current":-2.28009,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":77798958},{"date":"2022-07-08","current":-2.993706,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":102148250},{"date":"2022-07-15","current":-2.871869,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":97991054},{"date":"2022-07-22","current":-3.219975,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":109868758},{"date":"2022-07-29","current":-3.933591,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":134218050},{"date":"2022-08-05","current":-3.794349,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":129466969},{"date":"2022-08-12","current":-3.602891,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":122934232},{"date":"2022-08-19","current":-3.366632,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":118791610},{"date":"2022-08-26","current":-3.332966,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":117603693},{"date":"2022-09-02","current":-3.029969,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":106912449},{"date":"2022-09-09","current":-3.046802,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":107506407},{"date":"2022-09-16","current":-3.164634,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":111664113},{"date":"2022-09-23","current":-2.743805,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":96815162},{"date":"2022-09-30","current":-2.743805,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":96815162},{"date":"2022-10-07","current":-2.60914,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":92063497},{"date":"2022-10-14","current":-2.726972,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":96221204},{"date":"2022-10-21","current":-2.526258,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":89139007},{"date":"2022-10-28","current":-2.340999,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":82602146},{"date":"2022-11-04","current":-2.25679,"twenty":-15.295704,"median":-8.885204,"eighty":-4.403369,"marketCap":79630846},{"date":"2022-11-11","current":-2.058226,"twenty":-15.295704,"median":-8.885204,"eighty":-4.395441,"marketCap":72624520},{"date":"2022-11-18","current":-2.218203,"twenty":-15.295704,"median":-8.885204,"eighty":-4.356909,"marketCap":78442326},{"date":"2022-11-25","current":-2.16779,"twenty":-15.295704,"median":-8.885204,"eighty":-4.326654,"marketCap":76659546},{"date":"2022-12-02","current":-2.050158,"twenty":-15.295704,"median":-8.885204,"eighty":-4.28519,"marketCap":72499726},{"date":"2022-12-09","current":-1.949498,"twenty":-15.295704,"median":-8.885204,"eighty":-4.28519,"marketCap":68940108},{"date":"2022-12-16","current":-1.966135,"twenty":-15.295704,"median":-8.885204,"eighty":-4.28519,"marketCap":69528425},{"date":"2022-12-23","current":-2.050158,"twenty":-15.295704,"median":-8.885204,"eighty":-4.277572,"marketCap":72499726},{"date":"2022-12-30","current":-1.898917,"twenty":-15.295704,"median":-8.885204,"eighty":-4.167109,"marketCap":67151385},{"date":"2023-01-06","current":-1.915721,"twenty":-15.295704,"median":-8.885204,"eighty":-4.087119,"marketCap":67745645},{"date":"2023-01-13","current":-1.915721,"twenty":-15.295704,"median":-8.820349,"eighty":-4.037601,"marketCap":67745645},{"date":"2023-01-20","current":-1.898917,"twenty":-15.295704,"median":-8.787149,"eighty":-4.018556,"marketCap":67151385},{"date":"2023-01-27","current":-1.865307,"twenty":-15.295704,"median":-8.660434,"eighty":-3.942374,"marketCap":65962865},{"date":"2023-02-03","current":-2.226606,"twenty":-15.295704,"median":-8.65821,"eighty":-3.89512,"marketCap":78739456},{"date":"2023-02-10","current":-2.839973,"twenty":-15.295704,"median":-8.65821,"eighty":-3.828103,"marketCap":100429948},{"date":"2023-02-17","current":-2.604709,"twenty":-15.295704,"median":-8.65821,"eighty":-3.776943,"marketCap":92110307},{"date":"2023-02-24","current":-2.873582,"twenty":-15.295704,"median":-8.65821,"eighty":-3.712751,"marketCap":101618468},{"date":"2023-03-03","current":-4.033097,"twenty":-15.295704,"median":-8.622865,"eighty":-3.67574,"marketCap":142622412},{"date":"2023-03-10","current":-3.142455,"twenty":-15.295704,"median":-8.593355,"eighty":-3.643015,"marketCap":111126629},{"date":"2023-03-17","current":-3.293696,"twenty":-15.295704,"median":-8.587944,"eighty":-3.575879,"marketCap":116474969},{"date":"2023-03-24","current":-3.293696,"twenty":-15.295704,"median":-8.528499,"eighty":-3.539439,"marketCap":116474969},{"date":"2023-03-31","current":-3.219304,"twenty":-15.295704,"median":-8.500227,"eighty":-3.522328,"marketCap":124831732},{"date":"2023-04-06","current":-3.081334,"twenty":-15.295704,"median":-8.480723,"eighty":-3.485288,"marketCap":119481800},{"date":"2023-04-14","current":-3.127324,"twenty":-15.295704,"median":-8.436152,"eighty":-3.463542,"marketCap":121265111},{"date":"2023-04-21","current":-3.036281,"twenty":-15.295704,"median":-8.432009,"eighty":-3.438354,"marketCap":117734841},{"date":"2023-04-28","current":-2.668247,"twenty":-15.295704,"median":-8.432009,"eighty":-3.371016,"marketCap":103463951},{"date":"2023-05-05","current":-2.530234,"twenty":-15.295704,"median":-8.432009,"eighty":-3.35197,"marketCap":98112367},{"date":"2023-05-12","current":-2.698917,"twenty":-15.295704,"median":-8.432009,"eighty":-3.337424,"marketCap":104653192},{"date":"2023-05-19","current":-2.422904,"twenty":-15.295704,"median":-8.374823,"eighty":-3.325289,"marketCap":97815057},{"date":"2023-05-26","current":-2.435182,"twenty":-15.295704,"median":-8.319508,"eighty":-3.307528,"marketCap":98310717},{"date":"2023-06-02","current":-2.34663,"twenty":-15.295704,"median":-8.209385,"eighty":-3.293696,"marketCap":94735782},{"date":"2023-06-09","current":-2.272836,"twenty":-15.295704,"median":-8.150616,"eighty":-3.26071,"marketCap":91756669},{"date":"2023-06-16","current":-2.154767,"twenty":-15.251368,"median":-8.047584,"eighty":-3.226994,"marketCap":86990089},{"date":"2023-06-23","current":-2.080973,"twenty":-15.212269,"median":-7.963618,"eighty":-3.210521,"marketCap":84010976},{"date":"2023-06-30","current":-2.051456,"twenty":-15.17706,"median":-7.881655,"eighty":-3.188644,"marketCap":82819331},{"date":"2023-07-07","current":-2.199043,"twenty":-15.143699,"median":-7.854097,"eighty":-3.159259,"marketCap":88777556},{"date":"2023-07-14","current":-2.435182,"twenty":-15.075542,"median":-7.77697,"eighty":-3.130547,"marketCap":98310717},{"date":"2023-07-21","current":-2.420423,"twenty":-15.075542,"median":-7.713656,"eighty":-3.111103,"marketCap":97714894},{"date":"2023-07-28","current":-2.213801,"twenty":-15.075542,"median":-7.679069,"eighty":-3.081334,"marketCap":89373379},{"date":"2023-08-04","current":-2.051456,"twenty":-15.075542,"median":-7.636178,"eighty":-3.072214,"marketCap":82819331},{"date":"2023-08-11","current":-2.125249,"twenty":-15.075542,"median":-7.580054,"eighty":-3.046802,"marketCap":85798444},{"date":"2023-08-18","current":-2.585205,"twenty":-15.075542,"median":-7.54901,"eighty":-3.028517,"marketCap":103077297},{"date":"2023-08-25","current":-2.405885,"twenty":-15.075542,"median":-7.508363,"eighty":-2.994436,"marketCap":95927427},{"date":"2023-09-01","current":-2.615092,"twenty":-15.05964,"median":-7.464569,"eighty":-2.979469,"marketCap":104268942},{"date":"2023-09-08","current":-2.630035,"twenty":-14.974023,"median":-7.426283,"eighty":-2.957605,"marketCap":104864765},{"date":"2023-09-15","current":-2.913959,"twenty":-14.943096,"median":-7.37877,"eighty":-2.924085,"marketCap":116185393},{"date":"2023-09-22","current":-2.674865,"twenty":-14.779246,"median":-7.343841,"eighty":-2.90668,"marketCap":106652232},{"date":"2023-09-29","current":-2.839243,"twenty":-14.720226,"median":-7.260882,"eighty":-2.871869,"marketCap":113206280},{"date":"2023-10-06","current":-3.212827,"twenty":-14.680936,"median":-7.206838,"eighty":-2.869129,"marketCap":128101843},{"date":"2023-10-13","current":-3.063393,"twenty":-14.680936,"median":-7.165578,"eighty":-2.869129,"marketCap":122143618},{"date":"2023-10-20","current":-3.123167,"twenty":-14.680936,"median":-7.136779,"eighty":-2.869129,"marketCap":124526908},{"date":"2023-10-27","current":-3.108223,"twenty":-14.695384,"median":-7.121371,"eighty":-2.860163,"marketCap":123931086},{"date":"2023-11-03","current":-3.018563,"twenty":-14.695384,"median":-7.071858,"eighty":-2.860163,"marketCap":120356151},{"date":"2023-11-10","current":-3.033507,"twenty":-14.680936,"median":-7.016439,"eighty":-2.860163,"marketCap":120951973},{"date":"2023-11-17","current":-2.700296,"twenty":-14.669466,"median":-6.972171,"eighty":-2.839535,"marketCap":112610458},{"date":"2023-11-24","current":-3.144118,"twenty":-14.618707,"median":-6.90577,"eighty":-2.83248,"marketCap":131119152},{"date":"2023-12-01","current":-2.891995,"twenty":-14.589047,"median":-6.845457,"eighty":-2.83248,"marketCap":120604881},{"date":"2023-12-08","current":-2.862334,"twenty":-14.517188,"median":-6.812104,"eighty":-2.830792,"marketCap":119367908},{"date":"2023-12-15","current":-2.521227,"twenty":-14.415669,"median":-6.777373,"eighty":-2.808427,"marketCap":105142716},{"date":"2023-12-22","current":-2.639873,"twenty":-14.287524,"median":-6.681855,"eighty":-2.776719,"marketCap":110090609},{"date":"2023-12-29","current":-2.417411,"twenty":-14.296399,"median":-6.638019,"eighty":-2.772992,"marketCap":100813310},{"date":"2024-01-05","current":-2.461904,"twenty":-14.305275,"median":-6.617275,"eighty":-2.749672,"marketCap":102668770},{"date":"2024-01-12","current":-2.773349,"twenty":-14.248373,"median":-6.575787,"eighty":-2.743805,"marketCap":115656988},{"date":"2024-01-19","current":-2.58055,"twenty":-14.161872,"median":-6.477873,"eighty":-2.726972,"marketCap":107616663},{"date":"2024-01-26","current":-2.654703,"twenty":-14.050209,"median":-6.427732,"eighty":-2.706652,"marketCap":110709096},{"date":"2024-02-02","current":-2.58055,"twenty":-13.649882,"median":-6.381627,"eighty":-2.698973,"marketCap":107616663},{"date":"2024-02-09","current":-2.417411,"twenty":-13.238051,"median":-6.285353,"eighty":-2.681244,"marketCap":100813310},{"date":"2024-02-16","current":-2.59538,"twenty":-12.933495,"median":-6.243989,"eighty":-2.669972,"marketCap":108235149},{"date":"2024-02-23","current":-2.639873,"twenty":-12.831976,"median":-6.207035,"eighty":-2.661587,"marketCap":110090609},{"date":"2024-03-01","current":-2.899411,"twenty":-12.417746,"median":-6.161571,"eighty":-2.663252,"marketCap":120914124},{"date":"2024-03-08","current":-3.099626,"twenty":-12.070809,"median":-6.153218,"eighty":-2.663252,"marketCap":129263693},{"date":"2024-03-15","current":-2.936488,"twenty":-11.817645,"median":-6.113856,"eighty":-2.663252,"marketCap":122460340},{"date":"2024-03-22","current":-3.618702,"twenty":-11.567266,"median":-6.086816,"eighty":-2.663252,"marketCap":150910723},{"date":"2024-03-28","current":-3.57421,"twenty":-11.488578,"median":-6.024036,"eighty":-2.663252,"marketCap":149055263},{"date":"2024-04-05","current":-4.522257,"twenty":-11.365433,"median":-5.975182,"eighty":-2.661587,"marketCap":185711016},{"date":"2024-04-12","current":-6.33116,"twenty":-11.267947,"median":-5.92662,"eighty":-2.661587,"marketCap":259995422},{"date":"2024-04-19","current":-5.095076,"twenty":-11.226405,"median":-5.887611,"eighty":-2.661587,"marketCap":209234411},{"date":"2024-04-26","current":-5.275967,"twenty":-11.18915,"median":-5.843344,"eighty":-2.663252,"marketCap":216662852},{"date":"2024-05-03","current":-5.080002,"twenty":-11.094594,"median":-5.797202,"eighty":-2.663252,"marketCap":208615374},{"date":"2024-05-10","current":-4.899112,"twenty":-10.95276,"median":-5.721459,"eighty":-2.663252,"marketCap":201186934},{"date":"2024-05-17","current":-4.73768,"twenty":-10.887518,"median":-5.583924,"eighty":-2.663252,"marketCap":194377530},{"date":"2024-05-24","current":-4.601886,"twenty":-10.740008,"median":-5.431832,"eighty":-2.663252,"marketCap":188806199},{"date":"2024-05-31","current":-4.120184,"twenty":-10.699363,"median":-5.389816,"eighty":-2.663252,"marketCap":169042924},{"date":"2024-06-07","current":-3.938412,"twenty":-10.637573,"median":-5.275967,"eighty":-2.663252,"marketCap":161585148},{"date":"2024-06-14","current":-3.968707,"twenty":-10.515438,"median":-5.161273,"eighty":-2.663252,"marketCap":162828111},{"date":"2024-06-21","current":-3.54457,"twenty":-10.354985,"median":-5.095076,"eighty":-2.661587,"marketCap":145426633},{"date":"2024-06-28","current":-3.423388,"twenty":-10.282987,"median":-5.045979,"eighty":-2.661587,"marketCap":140454782},{"date":"2024-07-05","current":-3.120434,"twenty":-10.188696,"median":-4.936547,"eighty":-2.661587,"marketCap":128025156},{"date":"2024-07-12","current":-3.393093,"twenty":-9.987748,"median":-4.873473,"eighty":-2.661587,"marketCap":139211820},{"date":"2024-07-19","current":-3.665752,"twenty":-9.78217,"median":-4.715047,"eighty":-2.661587,"marketCap":150398484},{"date":"2024-07-26","current":-3.877821,"twenty":-9.519446,"median":-4.614838,"eighty":-2.661587,"marketCap":159099223},{"date":"2024-08-02","current":-3.355224,"twenty":-9.406328,"median":-4.550129,"eighty":-2.661587,"marketCap":137658116},{"date":"2024-08-09","current":-3.090138,"twenty":-9.316043,"median":-4.418507,"eighty":-2.661587,"marketCap":126782193},{"date":"2024-08-16","current":-3.262623,"twenty":-9.265805,"median":-4.351848,"eighty":-2.661587,"marketCap":144485250},{"date":"2024-08-23","current":-3.24856,"twenty":-9.156621,"median":-4.28313,"eighty":-2.661587,"marketCap":143862468},{"date":"2024-08-30","current":-3.789986,"twenty":-8.982488,"median":-4.208091,"eighty":-2.661587,"marketCap":167839546},{"date":"2024-09-06","current":-3.459505,"twenty":-8.948465,"median":-4.142906,"eighty":-2.661587,"marketCap":153204187},{"date":"2024-09-13","current":-4.036089,"twenty":-8.885204,"median":-4.116983,"eighty":-2.661587,"marketCap":178738218},{"date":"2024-09-20","current":-3.895459,"twenty":-8.852295,"median":-4.070455,"eighty":-2.661587,"marketCap":172510406},{"date":"2024-09-27","current":-3.811081,"twenty":-8.787149,"median":-4.037601,"eighty":-2.661587,"marketCap":168773718},{"date":"2024-10-04","current":-3.965774,"twenty":-8.65821,"median":-4.025662,"eighty":-2.661587,"marketCap":175624312},{"date":"2024-10-11","current":-3.797018,"twenty":-8.593355,"median":-3.981304,"eighty":-2.661587,"marketCap":168150937},{"date":"2024-10-18","current":-3.754829,"twenty":-8.592273,"median":-3.956208,"eighty":-2.661587,"marketCap":166282593},{"date":"2024-10-25","current":-3.52982,"twenty":-8.554441,"median":-3.936001,"eighty":-2.661587,"marketCap":156318093},{"date":"2024-11-01","current":-3.515757,"twenty":-8.49569,"median":-3.902413,"eighty":-2.661587,"marketCap":155695312},{"date":"2024-11-08","current":-4.218909,"twenty":-8.448242,"median":-3.895459,"eighty":-2.661587,"marketCap":186834375},{"date":"2024-11-15","current":-3.85674,"twenty":-8.407434,"median":-3.887172,"eighty":-2.661587,"marketCap":173850255},{"date":"2024-11-22","current":-3.870663,"twenty":-8.36085,"median":-3.866763,"eighty":-2.661587,"marketCap":174477873},{"date":"2024-11-29","current":-4.023819,"twenty":-8.24053,"median":-3.864433,"eighty":-2.661587,"marketCap":181381674},{"date":"2024-12-06","current":-2.847304,"twenty":-8.185237,"median":-3.85327,"eighty":-2.661587,"marketCap":128347932},{"date":"2024-12-13","current":-2.937805,"twenty":-8.083473,"median":-3.828498,"eighty":-2.659696,"marketCap":132427450},{"date":"2024-12-20","current":-1.448018,"twenty":-7.984356,"median":-3.825144,"eighty":-2.657177,"marketCap":65272298},{"date":"2024-12-27","current":-1.601174,"twenty":-7.923736,"median":-3.811081,"eighty":-2.64467,"marketCap":72176098},{"date":"2025-01-03","current":-1.615097,"twenty":-7.869679,"median":-3.79955,"eighty":-2.639873,"marketCap":72803717},{"date":"2025-01-10","current":-1.531557,"twenty":-7.797709,"median":-3.787123,"eighty":-2.630035,"marketCap":69038007},{"date":"2025-01-17","current":-1.726483,"twenty":-7.735493,"median":-3.776943,"eighty":-2.622243,"marketCap":77824663},{"date":"2025-01-24","current":-1.698636,"twenty":-7.701964,"median":-3.756639,"eighty":-2.60914,"marketCap":76569426},{"date":"2025-01-31","current":-1.740406,"twenty":-7.654465,"median":-3.740766,"eighty":-2.59538,"marketCap":78452281},{"date":"2025-02-07","current":-1.823945,"twenty":-7.614054,"median":-3.698577,"eighty":-2.592307,"marketCap":82217990},{"date":"2025-02-14","current":-1.963178,"twenty":-7.564429,"median":-3.694786,"eighty":-2.585205,"marketCap":88494173},{"date":"2025-02-21","current":-2.074564,"twenty":-7.547652,"median":-3.678103,"eighty":-2.58055,"marketCap":93515119},{"date":"2025-02-28","current":-2.18595,"twenty":-7.507469,"median":-3.665752,"eighty":-2.570262,"marketCap":98536065},{"date":"2025-03-07","current":-2.255566,"twenty":-7.449036,"median":-3.642121,"eighty":-2.550888,"marketCap":101674156},{"date":"2025-03-14","current":-2.339106,"twenty":-7.387714,"median":-3.618702,"eighty":-2.536057,"marketCap":105439866},{"date":"2025-03-21","current":-2.213796,"twenty":-7.37877,"median":-3.599455,"eighty":-2.525432,"marketCap":99791301},{"date":"2025-03-28","current":-2.116334,"twenty":-7.345188,"median":-3.582263,"eighty":-2.521227,"marketCap":95397974},{"date":"2025-04-04","current":-1.772658,"twenty":-7.267353,"median":-3.561469,"eighty":-2.506396,"marketCap":83398248},{"date":"2025-04-11","current":-1.812946,"twenty":-7.218845,"median":-3.550915,"eighty":-2.495545,"marketCap":85293662},{"date":"2025-04-17","current":-1.853234,"twenty":-7.198101,"median":-3.542423,"eighty":-2.465658,"marketCap":87189077},{"date":"2025-04-25","current":-1.772658,"twenty":-7.151824,"median":-3.529192,"eighty":-2.453457,"marketCap":83398248},{"date":"2025-05-02","current":-1.866663,"twenty":-7.115532,"median":-3.515322,"eighty":-2.440987,"marketCap":87820882},{"date":"2025-05-09","current":-1.853234,"twenty":-7.069303,"median":-3.485288,"eighty":-2.420747,"marketCap":87189077},{"date":"2025-05-16","current":-1.792764,"twenty":-6.998302,"median":-3.463992,"eighty":-2.414105,"marketCap":81013228},{"date":"2025-05-23","current":-1.792764,"twenty":-6.937269,"median":-3.454624,"eighty":-2.405047,"marketCap":81013228},{"date":"2025-05-30","current":-1.73674,"twenty":-6.878792,"median":-3.439451,"eighty":-2.385041,"marketCap":78481565},{"date":"2025-06-06","current":-1.820776,"twenty":-6.823339,"median":-3.413211,"eighty":-2.370613,"marketCap":82279060},{"date":"2025-06-13","current":-1.8768,"twenty":-6.787031,"median":-3.37448,"eighty":-2.345089,"marketCap":84810723},{"date":"2025-06-20","current":-4.607965,"twenty":-6.766726,"median":-3.366632,"eighty":-2.340242,"marketCap":208229314},{"date":"2025-06-27","current":-3.291403,"twenty":-6.665821,"median":-3.362798,"eighty":-2.340242,"marketCap":148735224},{"date":"2025-07-03","current":-3.053302,"twenty":-6.617577,"median":-3.35197,"eighty":-2.340242,"marketCap":137975655},{"date":"2025-07-11","current":-3.431463,"twenty":-6.576135,"median":-3.34411,"eighty":-2.340242,"marketCap":155064383},{"date":"2025-07-18","current":-4.047726,"twenty":-6.475151,"median":-3.34411,"eighty":-2.340242,"marketCap":182912680},{"date":"2025-07-25","current":-4.117756,"twenty":-6.41301,"median":-3.34411,"eighty":-2.340242,"marketCap":186077259},{"date":"2025-08-01","current":-5.098174,"twenty":-6.365123,"median":-3.34411,"eighty":-2.340242,"marketCap":230381369},{"date":"2025-08-08","current":-5.378293,"twenty":-6.282602,"median":-3.34411,"eighty":-2.340242,"marketCap":243039686},{"date":"2025-08-15","current":-5.266245,"twenty":-6.243968,"median":-3.34411,"eighty":-2.340242,"marketCap":237976359},{"date":"2025-08-22","current":-6.161626,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":248553816},{"date":"2025-08-29","current":-6.749203,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":272256113},{"date":"2025-09-05","current":-7.416183,"twenty":-6.195846,"median":-3.34411,"eighty":-2.339863,"marketCap":299161423},{"date":"2025-09-12","current":-9.433004,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":380517956},{"date":"2025-09-19","current":-7.368542,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":297239615},{"date":"2025-09-26","current":-7.320901,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":295317807},{"date":"2025-10-03","current":-6.749203,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":272256113},{"date":"2025-10-10","current":-7.543227,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":304286244},{"date":"2025-10-17","current":-8.019642,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":323504323},{"date":"2025-10-24","current":-8.146685,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":328629144},{"date":"2025-10-31","current":-8.051403,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":324785528},{"date":"2025-11-07","current":-8.919259,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":359793991},{"date":"2025-11-14","current":-8.839337,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":356570031},{"date":"2025-11-21","current":-9.920752,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":370073826},{"date":"2025-11-28","current":-9.903469,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":369429098},{"date":"2025-12-05","current":-10.888631,"twenty":-6.197486,"median":-3.34411,"eighty":-2.340242,"marketCap":406178589}],"updateTime":1765111580007},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GALT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589810817","title":"Galectin Therapeutics unveils new data on galectin-3 inhibitor belapectin for MASH cirrhosis and cancer therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2589810817","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589810817?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:15","pubTimestamp":1764969309,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics Inc. has released a corporate presentation highlighting its focused pipeline in the development of galectin-based therapeutics for chronic liver diseases and cancer. The company's lead candidate, belapectin, is a galectin-3 inhibitor with Fast Track Designation and patent protection through 2032. Clinical data indicate significant efficacy in patients with MASH cirrhosis, especially those without varices, showing a notable reduction in the development of new varices compared to placebo. Belapectin is also being evaluated in combination with Keytruda for melanoma and head and neck cancer, with encouraging clinical responses reported. The presentation also describes ongoing preclinical efforts to develop oral galectin-3 inhibitors. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-g","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL2yFFXm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"2589830296","title":"10X Fund, L.P. Reports Disposal of Galectin Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589830296","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589830296?lang=en_us&edition=fundamental","pubTime":"2025-12-05 05:57","pubTimestamp":1764885446,"startTime":"0","endTime":"0","summary":"10X Fund, L.P., a beneficial owner, has reported a disposal of common shares of Galectin Therapeutics Inc. . The Form 4 was filed by more than one reporting person, including 10X Fund, L.P. and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 04, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDL2Cm92p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"10X Fund, L.P. Reports Disposal of Galectin Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"2588023377","title":"Galectin Therapeutics Inc. Publishes Transcript of NAVIGATE Trial Update Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2588023377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588023377?lang=en_us&edition=fundamental","pubTime":"2025-12-04 01:01","pubTimestamp":1764781279,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL6CTVxg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"2584975817","title":"Galectin Therapeutics CEO Joel Lewis Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584975817","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584975817?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:01","pubTimestamp":1763586113,"startTime":"0","endTime":"0","summary":"Joel Lewis, President and CEO of Galectin Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL8nHHBG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Galectin Therapeutics CEO Joel Lewis Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"2583668125","title":"Galectin Therapeutics Chief Medical Officer Jamil Khurram Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583668125","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583668125?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:04","pubTimestamp":1763154240,"startTime":"0","endTime":"0","summary":"Jamil Khurram, Chief Medical Officer of Galectin Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL2CHvHJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Galectin Therapeutics Chief Medical Officer Jamil Khurram Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"2583272688","title":"Promising Phase 2 Data Boosts Confidence in Galectin Therapeutics’ Belapectin for Fibrotic Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2583272688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583272688?lang=en_us&edition=fundamental","pubTime":"2025-11-15 00:25","pubTimestamp":1763137533,"startTime":"0","endTime":"0","summary":"Matthew Keller, an analyst from H.C. Wainwright, reiterated the Buy rating on Galectin Therapeutics. The associated price target is $6.00. Matthew ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-2-data-boosts-confidence-in-galectin-therapeutics-belapectin-for-fibrotic-disease-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-2-data-boosts-confidence-in-galectin-therapeutics-belapectin-for-fibrotic-disease-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"2583501878","title":"Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583501878","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583501878?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:00","pubTimestamp":1763125200,"startTime":"0","endTime":"0","summary":"NORCROSS, Ga., Nov.  14, 2025  (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/14/3188253/27423/en/Galectin-Therapeutics-Reports-Financial-Results-for-the-quarter-ended-September-30-2025-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"2583506325","title":"Galectin Therapeutics: Submitted Navigate Data Package to FDA and Requested Feedback on Proposed Next Steps, Guidance Anticipated by Year-End","url":"https://stock-news.laohu8.com/highlight/detail?id=2583506325","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583506325?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:57","pubTimestamp":1763125025,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WQ0OH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"2583350639","title":"Galectin Therapeutics Inc: Qtrly Loss per Share $0.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2583350639","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583350639?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:57","pubTimestamp":1763125025,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WQ0OH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"2583506331","title":"Galectin Therapeutics reports Q3 2025 financial results and updates on belapectin trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2583506331","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583506331?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:56","pubTimestamp":1763124984,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics Inc. reported a net loss applicable to common stockholders of $8.2 million, or  per share, for the quarter ended September 30, 2025, compared to a net loss of $11.2 million, or  per share, for the same period in 2024. Research and development expenses were $2.6 million, down from $7.6 million in the prior year, primarily due to the conclusion of expenditures related to the NAVIGATE clinical trial. General and administrative expenses were $1.6 million, compared to $1.5 million in the previous year. As of September 30, 2025, the company held $11.5 million in cash and cash equivalents and entered into a $10 million line of credit in July 2025. The company submitted the NAVIGATE data package to the FDA and expects guidance by year-end, with sufficient cash to fund current plans through June 30, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL4YKbjz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"2583585315","title":"10X Fund, L.P. Reports Disposal of Galectin Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583585315","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583585315?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:34","pubTimestamp":1762983263,"startTime":"0","endTime":"0","summary":"10X Fund, L.P., a beneficial owner of Galectin Therapeutics Inc., has reported a disposal of common shares of the company. The Form 4 was filed by more than one reporting person, including 10X Fund, L.P. and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL5FhBln:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"2583484300","title":"Galectin Therapeutics CFO Jack W. Callicutt Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583484300","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583484300?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:01","pubTimestamp":1762981310,"startTime":"0","endTime":"0","summary":"Jack W. Callicutt, Chief Financial Officer of Galectin Therapeutics Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLgRM3L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Galectin Therapeutics CFO Jack W. Callicutt Reports Disposal of Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"2582871120","title":"Galectin Therapeutics unveils pipeline progress on galectin-3 inhibitor for MASH cirrhosis and cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2582871120","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582871120?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:21","pubTimestamp":1762780885,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics Inc. has provided an update on its focused pipeline of galectin-based therapeutics targeting chronic liver diseases and cancer. The company's lead compound, belapectin, is a galectin-3 inhibitor with Fast Track Designation and patent protection through 2032. Belapectin is being investigated for the treatment of metabolic dysfunction-associated steatohepatitis  cirrhosis and portal hypertension, with clinical data showing a significant reduction in the incidence of new varices in patients compared to placebo. Additionally, combination studies with belapectin and Keytruda are underway for melanoma and head and neck cancers, following FDA approval to proceed. Preclinical data indicate belapectin is well-tolerated in animal models and reduces markers of fibrosis and portal pressure. The company is also advancing a discovery program for oral galectin-3 inhibitors. You can access the full presentation through the link below.Disclaimer: This news brief was created by Pub","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL9PGg4L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"2582787235","title":"Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2582787235","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582787235?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:00","pubTimestamp":1762779600,"startTime":"0","endTime":"0","summary":"New biomarker analyses from the NAVIGATE trial demonstrated consistent antifibrotic effects of belapectin 2 mg/kgUsing established criteria for clinically meaningful worsening, a lower proportion of p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3184519/27423/en/Galectin-Therapeutics-Presented-NAVIGATE-Trial-Results-at-the-American-Association-for-the-Study-of-Liver-Diseases-AASLD-2025-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4117","GALT","LU1559883803.SGD","BK4107","LU0566484027.USD","LU1242518931.SGD","LU0979878070.USD","LU1242518857.USD","BK4139","AFG","BK4183","LU0053671581.USD","ELF","BK4588","BK4585"],"gpt_icon":0},{"id":"2582793898","title":"Galectin Therapeutics Reports Positive Phase 2 NAVIGATE Trial Results for Belapectin in MASH Cirrhosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2582793898","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582793898?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:56","pubTimestamp":1762779417,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics Inc. announced new results from the Phase 2b NAVIGATE trial evaluating belapectin, a galectin-3 inhibitor, in patients with compensated MASH cirrhosis and portal hypertension. The data were presented at the American Association for the Study of Liver Diseases  2025 Annual Meeting. In the 18-month, randomized, double-blind, placebo-controlled trial involving 355 patients, belapectin 2 mg/kg demonstrated consistent antifibrotic effects, including sustained improvements in liver stiffness and reductions in multiple serum biomarkers such as ELF, PRO-C3, and YKL-40. The rate of adverse events and serious adverse events was comparable to placebo, with no drug-related serious adverse events reported. Additionally, a lower proportion of patients treated with belapectin 2 mg/kg experienced clinically significant increases in liver stiffness compared to placebo, and the treatment was associated with a sustained reduction in new variceal development for patients completing 3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDLb3WNQC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"2581831836","title":"Galectin Therapeutics CFO Jack W. Callicutt Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2581831836","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581831836?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:08","pubTimestamp":1762549698,"startTime":"0","endTime":"0","summary":"Jack W. Callicutt, Chief Financial Officer of Galectin Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 07, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL6hGpRL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Galectin Therapeutics CFO Jack W. Callicutt Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"2581701652","title":"Galectin Therapeutics CEO Joel Lewis Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2581701652","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581701652?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:07","pubTimestamp":1762376827,"startTime":"0","endTime":"0","summary":"Joel Lewis, President and CEO of Galectin Therapeutics Inc., reported a disposal of common shares of Galectin Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL5SqwWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Galectin Therapeutics CEO Joel Lewis Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"2578521927","title":"10X Fund, L.P. Reports Disposal of Galectin Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2578521927","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578521927?lang=en_us&edition=fundamental","pubTime":"2025-10-25 08:18","pubTimestamp":1761351524,"startTime":"0","endTime":"0","summary":"10X Fund, L.P., a beneficial owner, has reported a disposal of common shares of Galectin Therapeutics Inc. The Form 4 filing was submitted by 10X Fund, L.P. and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251025:nNDL5kB3Vt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"2577001369","title":"Galectin Therapeutics Inc. Announces Date for 2025 Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2577001369","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577001369?lang=en_us&edition=fundamental","pubTime":"2025-10-22 20:02","pubTimestamp":1761134525,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics Inc. has scheduled its 2025 annual meeting of stockholders for December 3, 2025. During the meeting, stockholders will vote on the election of eleven nominees for director to serve until the 2026 annual meeting. Additionally, they will vote on a non-binding advisory resolution to approve the compensation paid to Galectin's named executive officers. The meeting will also include a non-binding vote to recommend the frequency with which Galectin will conduct stockholder advisory votes on executive compensation. The meeting will be conducted in an online-only format.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nNDLyQqNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"2576510288","title":"Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2576510288","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576510288?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:00","pubTimestamp":1760961600,"startTime":"0","endTime":"0","summary":"NORCROSS, Ga., Oct.  20, 2025  (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company man","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/20/3169313/27423/en/Galectin-Therapeutics-to-Present-at-the-H-C-Wainwright-9th-Annual-MASH-Investor-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}